GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients

EMİNGİL G. , AFACAN B., Tervahartiala T., TÖZ H. , Atilla G. , Sorsa T.

ARCHIVES OF ORAL BIOLOGY, cilt.55, ss.719-727, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Aim: The rationale of this study was to address whether local or systemic changes reflect proteolytic (matrix metalloproteinase-13) or oxidative (myeloperoxidase) stress in renal transplant patients receiving cyclosporine-A (CsA) and having gingival overgrowth (GO), in patients receiving CsA therapy and having no GO and patients receiving tacrolimus therapy.